Filing Details
- Accession Number:
- 0001140361-10-036762
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-09 19:18:03
- Reporting Period:
- 2010-09-08
- Filing Date:
- 2010-09-09
- Accepted Time:
- 2010-09-09 19:18:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1221599 | Steve Aselage | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Evp, Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-09-08 | 35,000 | $11.74 | 72,587 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-09-08 | 35,000 | $22.00 | 37,587 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2010-09-08 | 35,000 | $0.00 | 35,000 | $11.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
435,000 | 2006-07-06 | 2016-01-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 105-1 Trading plan executed on March 10, 2010.
- Original option vests 12/36ths on July 1, 2006 and 1/36th on the 1st of every month thereafter.